Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Jonas Jeffrey M, Director. Insider active across 2 companies, notably Sage Therapeutics, Inc.. Cumulatively, 15 reports have been published. Split: 1 buy · 0 sell. Activity tracked since 15 June 2021. The latest transaction was disclosed on 18 March 2024 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Jonas Jeffrey M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
JONAS JEFFREY M is Directeur de l'Innovation et Administrateur. He is linked to Sage Therapeutics, Inc. and Karuna Therapeutics, Inc., and his 15 filings cover transactions observed in the recent sample from 2016-01-07 to 2024-03-18, with 0 in purchases and 300205 in sales; the most frequent transaction nature is Levée d'options.